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Type II and type III isoenzymes of protein kinase C isolated from rabbit thymus cells were activated at relatively low concentrations but were 
inhibited at higher concentrations of arachidonic acid. Activation by &unsaturated fatty acids required Ca*‘; the maximal activity was approached 
at about 10m6 M Ca*+ concentration. The kinetics of activation and inhibition by arachidonic acid depended strongly on the nature of the substrate 
(synthetic oligopeptide or Hl histone), on the concentration of the protein substrate and on the stage of purification of the isoenzyme preparation 
investigated. Activation seemed to be favoured at high protein concentrations. 
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1. INTRODUCTION 
Protein kinase C (PKC) known as a key enzyme in 
mediating transmembrane signalling [l] is a family of 
proteins with close but distinct structures and individual 
enzymological properties [2]. Chromatography on a 
hydroxyapatite column separates three subfractions, 
types I, II and III, corresponding to subspecies with y, 
p(pr +,#r) and LY sequences, respectively. Type I enzyme 
is present exclusively in the central nervous tissue while 
type II and type III subfractions are widely distributed 
in many cell types [2-51. PKC functions as the 
transducer of a second messenger, diacylglycerol that 
may be provided by different signal routes [6]. Recent- 
ly, the potential role of &unsaturated fatty acids as ac- 
tivators of PKC has also been suggested [7-lo]. A possi- 
ble contribution of c&unsaturated fatty acids to the 
persistent activation of PKC under certain cir- 
cumstances [11,121 may have a great physiological im- 
portance .
acids on the activity of type II and type III PKC 
separated from rabbit thymus cells. The data presented 
in this paper show that the activation of these isoforms 
by arachidonic acid is strongly influenced by different 
conditions. 
2. EXPERIMENTAL 
2.1. Separation of PKC isoenzymes 
Initial analysis of a brain PKC preparation showed 
activation by &unsaturated fatty acids (such as 
arachidonic acid and oleic acid) in the absence of Ca2+ 
[ 13,141. However, detailed studies on separated brain 
isoenzymes have revealed that only type I PKC is ac- 
tivated in the absence of Ca2+ and at a low arachidonic 
acid concentration, type II and type III PKC require 
Ca2+ for activation and are activated at higher 
arachidonic acid concentrations than the type I enzyme 
[15,16,17]. 
Rabbit thymus cells were prepared by the method described in [18]. 
Isolated cells (1-2x lO’/ml) were suspended in a lysing medium com- 
prising 20 mM Tris-HCl (pH 7.5), 2 mM EGTA, 250 mM sucrose, 10 
mM dithioerythrytol, 2 mM phenylmethylsulphonyl fluoride, 0.02% 
leupeptine and 1 mM benzamidine. Cells were disrupted by sonication 
and the cytosolic extract was produced as previously described [19]. 
Separation of PKC isoenzymes directly from the cytosolic extract was 
performed on a hydroxyapatite column (Bio-Gel HPHT, 7.8x 100 
mm) joined to a high-performance liquid chromatographic system 
(DuPont 850). Freshly prepared cytosolic extract from 2-3 x lOa cells 
was diluted two times with 5 mM potassium phosphate (pH 7.5) 
filtered (Sartorius membrane 11307) and applied immediately onto 
the hydroxyapatite column. The isoenzymes were eluted from the 
column by a concentration gradient of potassium phosphate from 5 
to 200 mM containing 1 mM dithyoerythrytol. 0.4-ml fractions were 
collected and O.l-ml samples were assayed for PKC activity im- 
mediately after chromatography. 
We investigated the effects of c&unsaturated fatty 
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Isoenzymes were also separated from partially purified PKC 
preparations obtained by chromatography on a DEAE-Sephacel col- 
umn. In some experiments the purification was started from the 
cytosolic extract of 2-3~ 10’ cells, and the chromatography on 
DEAE-Sephacel was followed by chromatography on the Bio-Gel 
HPHT column joined to an HPLC system. However, in most cases 
the purification was started from the extract of about 1-2x lo9 cells. 
The cells were homogenized in the lysing medium in which the concen- 
tration of EGTA was increased to 10 mM. Chromatography was per- 
formed on a DEAE-Sephacel column as described [20], PKC was 
eluted by a concentration gradient of potassium phosphate (pH 7.5) 
containing 2 mM EGTA, 1 mM EDTA, 1 mM dithioerythrytol and 1 
mM benzamidine. Top fractions of PKC activity recovered from the 
DEAE-Sephacel were combined, concentrated on a Centricon con- 
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Fig. 1. Separation of type II and type III isoenzymes of protein kinase 
C from the cytosolic extract of rabbit thymus cells. Phos- 
photransferase activity was measured with the oIigo~p~de Ala-Ala- 
Ala-Ser-Phe-Lys-Ala Lys-Lys-amide as a substrate in the presence of 
0.5 mM EGTA (O--O); 0.5 mM Ca” + 25 #g/ml phospha- 
tidylserine + 50 ng/ml diacylglycerol (o----0); 0.5 mM EGTA + 
100 pM arachidonic acid (O---Q); and 0.5 mM Ca’+ + 100 ,uM 
arachidonic acid (M). 
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Fig. 2. The effect of Ca2+ on the activation of protein kinase C isoen- 
zymes by cis-unsaturated fatty acids. Phosphotransferase activity was 
determined with HI histone (1 mg/ml) as a substrate and is expressed 
as the percent of the activity of the corresponding enzyme fraction 
measured in the presence of 0.5 mM CaZf + 25 pg/ml phosphati- 
dylserine + 50 ng/ml diacylglycerol. The arrows indicate the values 
obtained in the presence of 0.5 mM EGTA. Type II (part A) and type 
III (part B) isoenzymes were activated by 100 pcM ~achidonic acid 
(M) or 100 pM oleic acid ( A---YA). of serum albumin. 
Fig. 3. The dual effect of arachidonic acid on the activity of protein 
kinase C of thymus cells. Activity was measured in the presence of 0.5 
mM Ca2’ with the oligopeptide substrate and is expressed as percent 
of the total activity produced by 25 pglml PhosphatidyIse~ne + 50 
nglml diacylglycerol. Part A shows results obtained with the cytosofic 
extract of thymus cells. Part B shows the activation of type II 
(M) and type III’ (0-0) isoenzymes separated from the 
cytosolic extract by hydroxyapatite chromatography on an HPLC 
system. Part C presents data obtained with a PKC preparation 
purified by chromatography on a DEAE-Sephacel column. The ac- 
tivity was determine in the absence (w) and presence (CLO) 
224 
centrator, diluted with 5 mM potassium phosphate and applied onto 
a hydroxyapatite column (14x 100 mM, Bio-Gel HT). PKC isoen- 
zymes were eluted with a concentration gradient of potassium 
phosphate (pH 7.5) from IO to 200 mM, the elution buffer contained 
0.5 mM EGTA, 0.5 mM EGTA and 10% (v/v) glycerol. 4-ml frac- 
tions were collected. This method also resulted in the complete separa- 
tion of the two peaks of PKC activity and the preparations obtained 
by this method could be stored at -20°C for 2-3 weeks without a 
significant change in PKC activity. 
2.2. Assay of PKC ffct~~~ty 
The activity of PKC was measured on the basis of [32P]phosphate 
incorporation into the oligopeptide Ala-Ala-Ala-Ser-Phe-Lys-Ala- 
Lys-Lys-amide designed previously as a selective substrate for PKC 
[21,22]. The assay was carried out in a mixture comprising 50 mM 
Tris-HCl (pH 7.5), 10 mM MgCl2, 0.01 mM [y-32P]ATP (about 
300000 cpm per reaction mixture) and the synthetic nonapeptide 
(0.75 mM). In some experiments the activity was measured with Hi 
histone (Sigma type 111s) as a substrate, as well. The reaction was 
stopped by glacial acetic acid and the peptide (or histone) was 
separated from the incubation mixture by phosphocellulose, as 
described [22], 
3. RESULTS AND DISCUSSION 
Thymus cells are known to possess two isoforms of 
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PKC type II and type III [23]. In the cytosolic extract of 
cells derived from rabbit thymus the two isoforms are 
generally present with similar amounts of activity 
(measured in more than ten independent preparations 
with the synthetic oligopeptide substrate in the presence 
of 25 pg/ml phosphatidylserine + 50 ng/ml diacyl- 
glycerol + 0.3 mM Ca*+). The chromatographic pat- 
tern of the peak of type III PKC was always hetero- 
genous (Fig. 1) but a functional difference between the 
distinct fractions of this peak was not observed. 
When the activity of the isoenzymes eparated irect- 
ly from the cytosolic extract was investigated in the 
presence of 100 PM arachidonic acid instead of 
phosphatidylserine and diacylglycerol an about 30% ac- 
tivation of type III enzyme was demonstrated while 
type II PKC was activated to a smaller extent (Fig. 1). 
The activation by &unsaturated fatty acids required 
Ca*+ . Ca*+ concentrations were effective in the order of 
magnitude of lo-’ M and the saturation was approachL 
ed at about 10e6 M (Fig. 2). However, the extent of ac- 
tivation produced by 100 ,uM arachidonic acid (com- 
pared to that observed in the presence of 25 pug/ml 
phosphatidylseine + 50 ng/ml diacylglycerol) varied 
strongly from experiment o experiment. Therefore, we 
analyzed the kinetics of this activation under different 
circumstances. In crude cytosolic extracts PKC activity 
was measured exclusively with the oligopeptide since it 
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Fig. 4. Comparison of the peptide kinase and the Hl histone kinase 
activities of protein kinase C isoenzymes eparated from thymus cells. 
The activity of type II (part A) and type III (part B) isoenzymes was 
assayed with the oligopeptide substrate Ala-Ala-Ala-Ser-Phe-Lys- 
Ala-Lys-Lys-amide (M) or with HI histone (A--A). The 
phosphotransferase activity measured in the presence of 0.5 mM Ca*’ 
+ 25 pg/ml phosphatidylserine + 50 ng/ml diacylglycerol was cor- 
rected with the value measured in the presence of 0.5 mM EGTA. 
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Fig. 5. The effect of arachidonic acid on the activity of type II and 
type III isoenzymes of protein kinase C under different cir- 
cumstances. The activity of the isoenzymes (type II, part A; type III, 
part B) was measured in the presence of 0.5 mM Ca2+ with the 
oligopeptide substrate (0.75 mg/ml, M) or with Hl histone (0.1 
mg/ml, U); (1.0 mg/ml, w). The phosphotransferase ac- 
tivity is expressed as the percent of the corresponding total activity 
produced in the presence of 25 /g/ml phosphatidylserine + 50 ng/ml 
diacylglycerol instead of arachidonic acid. 
is a selective substrate for PKC [21,22]. In these extracts 
a considerable activity was detected at arachidonic acid 
concentrations lower than 100 PM, the activation reach- 
ed the maximum at about 200 PM and no significant 
change was observed up to 500 PM concentration (Fig. 
3A). The kinetics of activation differed from this in 
purified preparations produced by hydroxyapatite HPL 
chromatography (Fig. 3B) or by chromatography on a 
DEAE-Sephacel column (Fig. 3C). In these latter cases 
the initial activation observed at relatively low 
arachidonic acid concentration was followed by a more 
or less strong inhibition at higher arachidonic acid con- 
centrations. The arachidonic acid concentration caus- 
ing the maximal activation and the magnitude of this 
activity depended on the preparation investigated. 
When PKC isoenzymes were purified under cir- 
cumstances leading to a very low protein concentration 
of the preparations (when the chromatography on 
DEAE-Sephacel was started from the cytosolic extract 
of 2x lo* cells and was follewd by a second 
chromatography on a hydroxyapatite HPLC column) 
the isoenzymes apparently lost their ability to be ac- 
tivated by arachidonic acid while they were activated by 
phosphatidylserine + diacylglycerol. This change was 
never observed when the isoenzymes were purified from 
the extract of 2 x lo9 cells (see section 2). 
225 
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Since the activity of PKC is generally measured with 
HI histone (Sigma type 111s) as phosphate acceptor we 
compared the activities obtained with the synthetic pep- 
tide and with Hl histone. In the presence of 25 pug/ml 
phosphatidylserine +50 ng/ml diacylglycerol both en- 
zymes exhibited a significantly higher maximal reaction 
velocity with the peptide than with Hl histone, though 
the ratio of peptide kinase activity/histone kinase ac- 
tivity was somewhat lower for type II than for type III 
PKC (Fig. 4). (This difference between type II and III 
isoforms is even more pronounced in the case of isoen- 
zymes prepared from rat brain [24,25].) The effects of 
arachidonic acid were investigated at substrate concen- 
trations producing saturation of the enzymes in the 
presence of 25 pug/ml phosphatidylserine +50 ng/ml 
diacylglycerol. These concentrations were 0.75 mg/ml 
for the synthetic peptide and 0.1 mg/ml for Hl histone. 
Hl histone was also applied at a concentration of 1 
mg/ml. In the presence of 25 kg/ml phosphatidylgly- 
cerol + 50 ng/ml diacylglycerol the activity of the isoen- 
zymes was not higher at 1.0 mg/ml Hl histone con- 
centration than at 0.1 mg/ml (Fig. 4). 
The kinetics of activation by arachidonic acid strong- 
ly depended on the nature of the substrate and on the 
concentration of the protein substrate (Fig. 5). Type III 
PKC was activated to a higher extent than type II in 
each case. Stimulation of peptide kinase activity was 
observed at arachidonic acid concentrations lower than 
50 pug/ml and the maximal activity was small. In the 
presence of 0.1 mg/ml HI histone the activation was 
significant and the maximal activity was observed at 
100 pg/ml arachidonic acid. When the histone concen- 
tration was 1.0 mg/ml the activation reached the max- 
imum at 300 pg/ml arachidonic acid and its value was 
higher than 50% and 100% for type II and type III 
isoenzymes, respectively. (Activation is expressed in 
percent of the activity measured in the presence of 25 
pg/ml phosphatidylserine +50 ng/ml diacylglycerol.) 
Our data show that arachidonic acid has a dual effect 
on the activity of PKC. The ratio of activation and in- 
hibition varies with different circumstances. Activation 
may be decreased or completely burried by the in- 
hibitory effect when the protein content of the reaction 
mixture is very low. Contrarily, high protein concentra- 
tion in the reactionmixture seems to potentiate the ac- 
tivation. These observations indicate that data concern- 
ing the activation of PKC isoenzymes by arachidonic 
acid can be compared only if they are produced under 
similar experimental conditions. They suggest also that 
under physiological conditions c&unsaturated fatty 
acids may exert a more pronounced positive effect on 
the activity of PKC than in purified preparations. 
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